Candesartan versus placebo for migraine prevention in patients with episodic migraine: a randomised, triple-blind, placebo-controlled, phase 2 trial
The Lancet Neurology2025Vol. 24(10), pp. 817–827
Citations Over TimeTop 10% of 2025 papers
Lise Rystad Øie, Tore Wergeland, Øyvind Salvesen, Gøril Bruvik Gravdahl, Irina Aschehoug, Sasha Gulati, Marte-Helene Bj Rk, Christofer Lundqvist, Karl Bjørnar Alstadhaug, Bendik Slagsvold Winsvold, Anne Hege Aamodt, Iben Cornelia Keim Larsen, Magne Geir B⊘e, Mark Braschinsky, Bernd Müller, Kjersti Grøtta Vetvik, Kai Ivar Müller, Kjersti Aaseth, Andrej Netland Khanevski, Ane Bakke Øvrevik, Håkon Magne Vegrim, Jenny Lindroos, Karine Eid, Helene Engstrand, Burcu Bezgal, M. Larsen, Joakim H⊘gsteggen Østhus, Lars Jacob Stovner, Erling Tronvik